Johnson Financial Group, LLC Amgen Inc Transaction History

Johnson Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $305,223 - $337,657	-1,392 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $121,714 - $139,291	-612 Reduced 30.54%	1,392 $313,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $90,214 - $105,697	-425 Reduced 17.5%	2,004 $426,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $229,842 - $254,993	984 Added 68.1%	2,429 $592,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $320,659 - $373,677	1,445 New	1,445 $360,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Johnson Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Johnson Financial Group, LLC with notifications on news.